Rezlidhia (Olutasidenib): Uses, Side Effects & Interactions
1. Introduction & Mechanism of Action of Rezlidhia Rezlidhia is a highly targeted, oral antineoplastic agent containing olutasidenib, specifically prescribed for the treatment of adult patients with relapsed or refractory acute myeloid leukemia possessing a susceptible isocitrate dehydrogenase 1 mutation. Its most critical and potentially fatal clinical side effect is differentiation syndrome, alongside significant hepatotoxicity … Read more